论文部分内容阅读
目的评价复方半边莲辅助治疗慢性阻塞性肺病(慢阻肺)的临床疗效。方法将住院的慢阻肺急性加重期患者随机分成治疗组和对照组,治疗组35例,对照组30例,对照组常规给予吸氧、抗感染、平喘及祛痰等治疗,治疗组在对照组治疗的基础上,再加用雾化吸入复方半边莲注射液治疗。结果治疗组总有效率94.29%,对照组总有效率73.33%(χ2=3.96,P<0.05)。结论应用复方半边莲辅助治疗,对减轻慢阻肺患者急性加重期症状,有明显效果。
Objective To evaluate the clinical efficacy of Compound Lobelia Compound in the treatment of chronic obstructive pulmonary disease (COPD). Methods The hospitalized patients with COPD were randomly divided into treatment group and control group. The treatment group was 35 cases and the control group 30 cases. The control group was routinely given oxygen, anti-infective, antiasthmatic and expectorant treatment. Control group based on the treatment, coupled with atomized inhalation compound Lobelia injection treatment. Results The total effective rate was 94.29% in the treatment group and 73.33% in the control group (χ2 = 3.96, P <0.05). Conclusion Compound Lobelia adjuvant treatment of COPD in patients with acute exacerbation of symptoms, have a significant effect.